- Banking and Finance Law
- Bankruptcy and Insolvency
- Capital Markets
- Commercial and Company law
- Mergers and Acquisitions
- Admitted in Iceland 2011
- Reykjavik University, M.L. degree 2010
BBA//Fjeldco acted for CIT BANK in relation to USD 65 million refinancing of Icelandair
In December 2019 CIT Bank served as sole lender and facility agent on a $30 and $35 million secured financing for Icelandair Group, the nationalcarrier of Iceland. The financing is part of a refinancing due to theredemption of bonds, issued by Icelandair, earlier this year.
Alvotech hf. and Icelandic biopharmaceutical
BBA//Fjeldco acted as legal advisor to Alvotech hf., an Icelandic biopharmaceutical company focused on the development and manufacturing of high quality biosimilars for global markets, during the restructuring of Alvotechhf. BBA also advised on the issuance of USD 300,000,000 convertible bond, issued by Alvotech Holding A.S., whereas Alvotech hf., Glycothera GMBH, AlvotechGermany GMBH and Alvotech Swiss AG acted as guarantors.
BBA//Fjeldco acted as legal adviser to Nox Holding ehf., in relation to acquisition of all shares, issued by Nox Medical ehf., the subsequent restructuring of the Nox Group, and investment by the private equity fund Alfa Framtak, establishing a world leader in sleep diagnostic technology and sleep health solutions.
Sale of Icelandair Hotels
BBA//Fjeldco advised Icelandair hf. in relation to the sale of Icelandair Hotels and related estates to Berjaya Corporation
Takeover of the Nordic travel group Travelco
BBA//Fjeldco advised Arion Bank (Iceland's largest bank listed in Reykjavik and Stockholm) in relation to its takeover of the Nordic travel group Travelco.
Aquisition of Lyfja
BBA//Fjeldco advised Stefnir hf., Iceland’s largest fundmanagement company on all aspects in relation to one of its fund’s acquisition of Iceland's leading pharmacy retail company Lyfja.
BBA//Fjeldco was a legal adviser to Alvotech hf. in relation to an equipment financing with respect to a state-of-the-art 12,000 m2 manufacturing and laboratory facility in the Science Park of the University of Iceland of a value of USD 25,000,000.
BBA acted as a legal advisor to Alvotech hf., and Icelandic biopharmaceutical company focused on the development and manufacturing of high quality biosimilars for global markets, during the restructuring of Alvotech hf. BBA also advised on the issuance of USD 300,000,000 by Alvotech Holding A.S. whereas Alvotech hf., Glycothera GMBH, Alvotech Germany GMBH and Alvotech Swiss AG acted as guarantors.